MIRCERA® is a long-acting erythropoiesis-stimulating agent (ESA) used for the treatment of anemia associated with chronic kidney disease (CKD).

Jan 30, 2025 · Mircera (methoxy polyethylene glycol-epoetin beta) is commonly used to treat anemia due to chronic kidney disease. Mircera may also be used for other conditions as determined by your …

Jun 5, 2024 · Mircera is not indicated and is not recommended for the treatment of anemia due to cancer chemotherapy. A dose-ranging study of Mircera was terminated early because of more …

Oct 17, 2024 · Mircera (Methoxy Polyethylene glycol-epoetin beta) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison …

What is MIRCERA ®? MIRCERA ® is a Continuous Erythropoetin Receptor Activator (C.E.R.A.) indicated for: the treatment of symptomatic anaemia associated with chronic kidney disease (CKD) in …

Mircera is not indicated and is not recommended for the treatment of anemia due to cancer chemotherapy. A dose-ranging study of Mircera was terminated early because of more deaths among...

MIRCERA is indicated for the treatment of anaemia associated with chronic kidney disease (CKD). Adult patients on dialysis and adult patients not on dialysis.

What is Mircera? Mircera is a prescription medicine used to treat anemia. People with anemia have a lower-than-normal number of RBCs. Mircera works like the human protein called erythropoietin to …

Jun 26, 2024 · Mircera is a man-made form of a protein normally produced by the kidneys that helps your body produce red blood cells. When your body does not make enough of this protein because …

Mircera is an erythropoietin receptor activator with greater activity in vivo as well as increased half-life, in contrast to erythropoietin. A primary growth factor for erythroid development,...